SCNINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Scinai Immunotherapeutics Ltd.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026
$0.75−0.00 (-0.32%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Scinai Immunotherapeutics's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Mark Angelo | 93,274 | 9.90% | 13G (passive) | Mar 24, 2025 |
| Lck Jnk 1 LLC | 317,366 | 6.33% | 13G (passive) amendment | Apr 27, 2026 |
| Stone Daniel E. | 0 | 9.90% | 13G (passive) amendment | Jun 4, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Amir Reichman | Chief Executive Officer, Director | 711,637,600 | 5.13% | Jun 18, 2026 |
| Elad Mark | Chief Operating Officer | 160,355,016 | 1.16% | Mar 26, 2026 |
| Mark Germain | Director | 120,000,000 | 0.86% | Jun 18, 2026 |
| Yael Margolin | Director | 66,800 | 0.00% | Mar 18, 2026 |
| Uri Ben-Or | Director | 33,329,004 | 0.24% | Mar 18, 2026 |
| Samuel J. Moed | Director | – | – | Mar 18, 2026 |
| Adi Raviv | Director | 66,800 | 0.00% | Mar 18, 2026 |
| Jay Green | Director | – | – | Mar 18, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Amir Reichman Chief Executive Officer, Director | Jun 16, 2026 | Award | +400,000,000 | – | – | 711,637,600 |
| Mark Germain Director | Jun 16, 2026 | Award | +120,000,000 | – | – | 120,000,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.